Quick Answer
VOLITIONRX LTD reported Operating Income of -$21.74 million for fiscal year 2025.
VOLITIONRX LTD Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$21.74M | +19.6% |
| 2024 | -$27.02M | +24.9% |
| 2023 | -$35.99M | -13.2% |
| 2022 | -$31.78M | -12.2% |
| 2021 | -$28.33M | -33.3% |
| 2020 | -$21.25M | -32.4% |
| 2019 | -$16.04M | +10.4% |
| 2018 | -$17.90M | -21.8% |
| 2017 | -$14.70M | -18.2% |
| 2016 | -$12.43M | -24.2% |
| 2015 | -$10.01M | -68.1% |
| 2014 | -$5.95M | -30.1% |
| 2013 | -$4.58M | -12.1% |
| 2012 | -$4.08M | -56.5% |
| 2011 | -$2.61M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$5.10M | +13.1% | +19.0% |
| June 30, 2025 | -$6.30M | +9.9% | -14.1% |
| March 31, 2025 | -$5.52M | +34.1% | +5.9% |
| September 30, 2024 | -$5.87M | +32.2% | +16.0% |
| June 30, 2024 | -$6.99M | +26.8% | +16.6% |
| March 31, 2024 | -$8.38M | +7.3% | +3.1% |
| September 30, 2023 | -$8.65M | -8.3% | +9.4% |
| June 30, 2023 | -$9.55M | -17.9% | -5.6% |
- VOLITIONRX LTD showed an increase of +19.6% in Operating Income compared to the prior fiscal year.
- Over the 2011–2025 period, VOLITIONRX LTD’s operating income has declined by 733.4% (from -$2.61 million to -$21.74 million).
- The most recent figure is from VOLITIONRX LTD’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: